2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow CKD732: new trials by email Literature Review of CKD732 trials Research Report on CKD732
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ZGN-440 (Beloranib for Subcutaneous Injection) for Treatment of Obesity ZGN-440, ZGN-440 sterile diluent - Obesity | Phase 1 | Completed | Zafgen, Inc. | 25 | 2011-12-01 | 2012-07-18 |
| Pharmacokinetics, Safety, Tolerability and Efficacy of Intravenous Doses of ZGN-433 in Obese Female Volunteers ZGN-433, Normal Saline - Obesity | Phase 1 | Completed | Zafgen, Inc. | 25 | 2011-06-01 | 2011-12-30 |
Obesity (2) · Overweight (2)
Zafgen, Inc. (2)
Australia (2)
J K Marjason, MD (2)